Shendelman Shoshana (CIK 0001775490)

Latest company ownership

Shares held
1,870,771
Last filed at
Aug 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 5, 2024 Aug 14, 2024 Applied Therapeutics, Inc. CEO Sell 17.5 -777,014 -12.50% ✗ $4.7M
Jun 6, 2024 Jun 10, 2024 Applied Therapeutics, Inc. CEO Sell 42.5 -61,795 -0.76% ✗ $267K
Mar 14, 2024 Mar 18, 2024 Applied Therapeutics, Inc. CEO Sell 37.5 -318,573 -3.76% ✗ $1.7M
Nov 30, 2023 Dec 1, 2023 Applied Therapeutics, Inc. CEO Sell 52.5 -3,968 -0.06% ✗ $7.8K
Sep 27, 2023 Sep 29, 2023 Applied Therapeutics, Inc. CEO Sell 40.0 -115,632 -1.64% ✗ $312.2K
Jan 11, 2023 Jan 13, 2023 Applied Therapeutics, Inc. CEO Sell 91.3 +1,948,492 38.22% ✗ $14.4K
Oct 14, 2022 Oct 14, 2022 Applied Therapeutics, Inc. CEO Buy 68.8 +50,000 0.99% ✗ $32.3K
Oct 13, 2022 Oct 13, 2022 Applied Therapeutics, Inc. CEO Buy 78.8 +73,256 1.47% ✗ $40.9K
Oct 12, 2022 Oct 12, 2022 Applied Therapeutics, Inc. CEO Buy 68.8 +38,153 0.77% ✗ $19.9K
Sep 13, 2021 Sep 14, 2021 Applied Therapeutics, Inc. CEO Buy 65.0 +10,001 0.21% ✗ $145K
Jul 20, 2020 Jul 22, 2020 Applied Therapeutics, Inc. CEO Sell 42.5 -45,000 -0.51% ✓ $1.2M
Jul 7, 2020 Jul 9, 2020 Applied Therapeutics, Inc. CEO Sell 42.5 -45,000 -0.64% ✓ $1.4M
Feb 28, 2020 Jun 1, 2020 Applied Therapeutics, Inc. CEO Sell 16.3 -125,000 -1.79% ✗ $5.3M
May 16, 2019 May 20, 2019 Applied Therapeutics, Inc. CEO Buy 92.5 +125,000 2.63% ✗ $1.3M